The North America Protein Therapeutics Market would witness market growth of 6.2% CAGR during the forecast period (2022-2028).
A significant class of medications known as therapeutic proteins helps patients in need of cutting-edge treatments. Noncovalent binders and proteins that alter covalent bonds (nearly every enzyme), and albumin are examples of substances that have been developed in laboratories for use in pharmaceuticals. Therapeutic proteins have completely changed how diseases are treated in vitro.
A wide variety of indications, including cancer, genetic abnormalities, infectious diseases, or metabolic disorders, can be successfully treated with therapeutic protein products. These proteins may reduce morbidity, decrease the progression of the illness, and/or take the role of vital proteins that a patient cannot manufacture on their own.
Since they may catalyze biochemical activities, generate membrane receptors and channels, provide both intracellular and extracellular scaffolding support, and transport molecules between organs and inside cells, proteins play the most dynamic and varied roles of any macromolecule in the body. With alternative gene splicing and post-translational protein modification (such as cleavage, phosphorylation, acylation, and glycosylation), the number of numbers of functional proteins is likely to be much higher than the current estimate of 25,000–40,000 genetic variations in the human genome.
The key regional market for protein therapies is America. The market for protein therapies is being fuelled by a variety of government initiatives as well as growing worries about the safety and health of medical personnel. Another important factor driving the development of the market for protein therapies is the rising incidence of cancer. With increasing healthcare spending, cases of multiple rheumatoid arthritis, sclerosis, and chronic inflammatory demyelinating polyneuropathy, the protein therapeutics market is anticipated to expand in the coming years.
The US market dominated the North America Protein Therapeutics Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $130,460.1 million by 2028. The Canada market is experiencing a CAGR of 8.6% during (2022 - 2028). Additionally, The Mexico market is expected to witness a CAGR of 7.7% during (2022 - 2028).
Based on Product, the market is segmented into Monoclonal Antibodies, Human Growth Hormone, Fusion Protein, Insulin, Erythropoietin, Interferon and Follicle Stimulating Hormone. Based on Application, the market is segmented into Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders and Others. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
Free Valuable Insights: The Global Protein Therapeutics Market is Estimated to reach $490.2 Billion by 2028, at a CAGR of 6.9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Baxter International, Inc., Amgen, Inc., F. Hoffmann-La Roche Ltd., Eli Lilly and Company, Merck & Co., Inc., Johnson & Johnson (Janssen Global Services, LLC), Pfizer, Inc., Novo Nordisk A/S and Sanofi S.A.
Scope of the Study
Market Segments Covered in the Report:
By Product
- Monoclonal Antibodies
- Human Growth Hormone
- Fusion Protein
- Insulin
- Erythropoietin
- Interferon
- Follicle Stimulating Hormone
By Application
- Metabolic Disorders
- Immunologic Disorders
- Hematological Disorders
- Cancer
- Hormonal Disorders
- Genetic Disorders
- Others
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Baxter International, Inc.
- Amgen, Inc.
- F. Hoffmann-La Roche Ltd.
- Eli Lilly And Company
- Merck & Co., Inc.
- Johnson & Johnson (Janssen Global Services, LLC)
- Pfizer, Inc.
- Novo Nordisk A/S
- Sanofi S.A.
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Protein Therapeutics Market, by Product
1.4.2 North America Protein Therapeutics Market, by Application
1.4.3 North America Protein Therapeutics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market composition and scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Product Launches and Product Expansions
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Acquisition and Mergers: 2018, Mar – 2022, Jun) Leading Players
Chapter 4. North America Protein Therapeutics Market by Product
4.1 North America Monoclonal Antibodies Market by Country
4.2 North America Human Growth Hormone Market by Country
4.3 North America Fusion Protein Market by Country
4.4 North America Insulin Market by Country
4.5 North America Erythropoietin Market by Country
4.6 North America Interferon Market by Country
4.7 North America Follicle Stimulating Hormone Market by Country
Chapter 5. North America Protein Therapeutics Market by Application
5.1 North America Metabolic Disorders Market by Country
5.2 North America Immunologic Disorders Market by Country
5.3 North America Hematological Disorders Market by Country
5.4 North America Cancer Market by Country
5.5 North America Hormonal Disorders Market by Country
5.6 North America Genetic Disorders Market by Country
5.7 North America Others Market by Country
Chapter 6. North America Protein Therapeutics Market by Country
6.1 US Protein Therapeutics Market
6.1.1 US Protein Therapeutics Market by Product
6.1.2 US Protein Therapeutics Market by Application
6.2 Canada Protein Therapeutics Market
6.2.1 Canada Protein Therapeutics Market by Product
6.2.2 Canada Protein Therapeutics Market by Application
6.3 Mexico Protein Therapeutics Market
6.3.1 Mexico Protein Therapeutics Market by Product
6.3.2 Mexico Protein Therapeutics Market by Application
6.4 Rest of North America Protein Therapeutics Market
6.4.1 Rest of North America Protein Therapeutics Market by Product
6.4.2 Rest of North America Protein Therapeutics Market by Application
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Baxter International, Inc.
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Approvals and Trials:
7.2.5.2 Acquisition and Mergers:
7.3 Amgen, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expenses
7.3.5 Recent strategies and developments:
7.3.5.1 Partnerships, Collaborations, and Agreements:
7.3.5.2 Acquisition and Mergers:
7.4 F. Hoffmann-La Roche Ltd.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Eli Lilly And Company
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional Analysis
7.5.4 Research & Development Expenses
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.5.5.2 Acquisition and Mergers:
7.6 Merck & Co., Inc.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental and Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Partnerships, Collaborations, and Agreements:
7.6.5.2 Acquisition and Mergers:
7.7 Johnson & Johnson (Janssen Global Services, LLC)
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental &Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Product Launches and Product Expansions:
7.7.5.2 Acquisition and Mergers:
7.8 Pfizer, Inc.
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional & Segmental Analysis
7.8.4 Research & Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Acquisition and Mergers:
7.9 Novo Nordisk A/S
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental & Regional Analysis
7.9.4 Research & Development Expenses
7.9.5 Recent strategies and developments:
7.9.5.1 Partnerships, Collaborations, and Agreements:
7.10. Sanofi S.A.
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
TABLE 1 North America Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 2 North America Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 3 Partnerships, Collaborations and Agreements– Protein Therapeutics Market
TABLE 4 Product Launches And Product Expansions– Protein Therapeutics Market
TABLE 5 Acquisition and Mergers– Protein Therapeutics Market
TABLE 6 Trial and Approvals– Protein Therapeutics Market
TABLE 7 North America Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 8 North America Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 9 North America Monoclonal Antibodies Market by Country, 2018 - 2021, USD Million
TABLE 10 North America Monoclonal Antibodies Market by Country, 2022 - 2028, USD Million
TABLE 11 North America Human Growth Hormone Market by Country, 2018 - 2021, USD Million
TABLE 12 North America Human Growth Hormone Market by Country, 2022 - 2028, USD Million
TABLE 13 North America Fusion Protein Market by Country, 2018 - 2021, USD Million
TABLE 14 North America Fusion Protein Market by Country, 2022 - 2028, USD Million
TABLE 15 North America Insulin Market by Country, 2018 - 2021, USD Million
TABLE 16 North America Insulin Market by Country, 2022 - 2028, USD Million
TABLE 17 North America Erythropoietin Market by Country, 2018 - 2021, USD Million
TABLE 18 North America Erythropoietin Market by Country, 2022 - 2028, USD Million
TABLE 19 North America Interferon Market by Country, 2018 - 2021, USD Million
TABLE 20 North America Interferon Market by Country, 2022 - 2028, USD Million
TABLE 21 North America Follicle Stimulating Hormone Market by Country, 2018 - 2021, USD Million
TABLE 22 North America Follicle Stimulating Hormone Market by Country, 2022 - 2028, USD Million
TABLE 23 North America Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 24 North America Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 25 North America Metabolic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 26 North America Metabolic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 27 North America Immunologic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 28 North America Immunologic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 29 North America Hematological Disorders Market by Country, 2018 - 2021, USD Million
TABLE 30 North America Hematological Disorders Market by Country, 2022 - 2028, USD Million
TABLE 31 North America Cancer Market by Country, 2018 - 2021, USD Million
TABLE 32 North America Cancer Market by Country, 2022 - 2028, USD Million
TABLE 33 North America Hormonal Disorders Market by Country, 2018 - 2021, USD Million
TABLE 34 North America Hormonal Disorders Market by Country, 2022 - 2028, USD Million
TABLE 35 North America Genetic Disorders Market by Country, 2018 - 2021, USD Million
TABLE 36 North America Genetic Disorders Market by Country, 2022 - 2028, USD Million
TABLE 37 North America Others Market by Country, 2018 - 2021, USD Million
TABLE 38 North America Others Market by Country, 2022 - 2028, USD Million
TABLE 39 North America Protein Therapeutics Market by Country, 2018 - 2021, USD Million
TABLE 40 North America Protein Therapeutics Market by Country, 2022 - 2028, USD Million
TABLE 41 US Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 42 US Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 43 US Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 44 US Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 45 US Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 46 US Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 47 Canada Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 48 Canada Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 49 Canada Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 50 Canada Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 51 Canada Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 52 Canada Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 53 Mexico Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 54 Mexico Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 55 Mexico Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 56 Mexico Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 57 Mexico Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 58 Mexico Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 59 Rest of North America Protein Therapeutics Market, 2018 - 2021, USD Million
TABLE 60 Rest of North America Protein Therapeutics Market, 2022 - 2028, USD Million
TABLE 61 Rest of North America Protein Therapeutics Market by Product, 2018 - 2021, USD Million
TABLE 62 Rest of North America Protein Therapeutics Market by Product, 2022 - 2028, USD Million
TABLE 63 Rest of North America Protein Therapeutics Market by Application, 2018 - 2021, USD Million
TABLE 64 Rest of North America Protein Therapeutics Market by Application, 2022 - 2028, USD Million
TABLE 65 Key Information – Abbott Laboratories
TABLE 66 Key Information – Baxter International, Inc.
TABLE 67 Key Information – Amgen, Inc.
TABLE 68 KEY INFORMATION – F. Hoffmann-La Roche Ltd.
TABLE 69 Key Information – Eli Lilly And Company
TABLE 70 KEY INFORMATION - MERCK & CO., INC.
TABLE 71 Key information –Johnson & Johnson
TABLE 72 Key Information – Pfizer, Inc.
TABLE 73 Key information – Novo Nordisk A/S
TABLE 74 Key Information – Sanofi S.A.
List of Figures
FIG 1 Methodology for the research
FIG 2 KBV Cardinal Matrix
FIG 3 Key Leading Strategies: Percentage Distribution (2017-2021)
FIG 4 Key Strategic Move: (Acquisition and Mergers: 2018, Mar – 2022, Jun) Leading Players
FIG 5 Swot analysis: Abbott laboratories
FIG 6 Recent strategies and developments: Merck & Co., Inc.